Azenta/$AZTA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Azenta
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
Ticker
$AZTA
Sector
Primary listing
Employees
3,000
Headquarters
Website
Azenta Metrics
BasicAdvanced
$1.4B
-
-$2.41
1.65
-
Price and volume
Market cap
$1.4B
Beta
1.65
52-week high
$55.64
52-week low
$23.91
Average daily volume
591K
Financial strength
Current ratio
2.764
Quick ratio
1.807
Long term debt to equity
3.145
Total debt to equity
3.145
Profitability
EBITDA (TTM)
34.049
Gross margin (TTM)
42.10%
Net profit margin (TTM)
-16.68%
Operating margin (TTM)
-8.31%
Effective tax rate (TTM)
-4.77%
Revenue per employee (TTM)
$220,000
Management effectiveness
Return on assets (TTM)
-1.59%
Return on equity (TTM)
-9.15%
Valuation
Price to revenue (TTM)
2.107
Price to book
0.83
Price to tangible book (TTM)
1.62
Price to free cash flow (TTM)
26.709
Free cash flow yield (TTM)
3.74%
Free cash flow per share (TTM)
1.14
Growth
Revenue change (TTM)
12.46%
Earnings per share change (TTM)
-12.98%
3-year revenue growth (CAGR)
6.42%
10-year revenue growth (CAGR)
2.36%
3-year earnings per share growth (CAGR)
-56.39%
10-year earnings per share growth (CAGR)
36.16%
What the Analysts think about Azenta
Analyst ratings (Buy, Hold, Sell) for Azenta stock.
Bulls say / Bears say
Adjusted EBITDA margin increased by 260 basis points to 12.3% in Q3, reflecting effective cost controls and operational efficiency. (Reuters)
Q3 revenue in the Multiomics segment rose 4% year-over-year, fueled by strong demand for Next-Generation Sequencing services, underscoring the strength of high-margin offerings. (Reuters)
Management reaffirmed its full-year organic revenue growth target of 3–5% and projected a 300 basis point increase in adjusted EBITDA margin, demonstrating confidence in continued growth and profitability. (Reuters)
Q3 revenue remained flat at $144 million, falling about 3.6% short of analyst expectations, pointing to stalled revenue growth. (Reuters)
Sample Management Solutions revenue dropped 4% year-over-year in Q3, showing continued softness in core cold-chain lines. (Reuters)
Wall Street’s median 12-month price target stands at $32.50, just 0.3% above the latest closing price, with analysts maintaining a consensus “hold” rating, suggesting minimal conviction and upside. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 5 Sept 2025.
Azenta Financial Performance
Revenues and expenses
Azenta Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Azenta stock?
Azenta (AZTA) has a market cap of $1.4B as of September 18, 2025.
What is the P/E ratio for Azenta stock?
The price to earnings (P/E) ratio for Azenta (AZTA) stock is 0 as of September 18, 2025.
Does Azenta stock pay dividends?
No, Azenta (AZTA) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Azenta dividend payment date?
Azenta (AZTA) stock does not pay dividends to its shareholders.
What is the beta indicator for Azenta?
Azenta (AZTA) has a beta rating of 1.65. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.